Effects of endothelin-1 on epicardial coronary tone, coronary blood flow, ECG-ST change and regional wall motion in anesthetized dogs
Tóm tắt
The effects of intracoronaryadministrated endothelin-1 on coronary hemodynamics and regional myocardial function were studied in anesthetized open-chest dogs. Epicardial coronary diameter (CoD) and coronary blood flow (CBF) were measured by a sonomicrometer of 10 MHz piezoelectric crystals and an electromagnetic flow probe on the left circumflex coronary artery (LCX). Regional wall motion was sonomicrometrically measured at regions supplied by the LCX and left anterior descending artery (LAD) and electrocardiograms were recorded. Endothelin-1, administered as a bolus injections into the LCX via an intracoronary cannula, in a dose-dependent manner reduced COD and CBF. The extent of the reduction of COD and CBF at a dose of 300 pmol was 12.3±1.5% (P<0.01) and 86±5% (p<0.01), respectively, of the control. The extent of CBF reduction and deterioration of systolic wall motion were linearly related with the dosage of endothelin-1. ST-elevation (lead II) and fatal ECG abnormalities, including complete atrioventricular block or ventricular fibrillation, were observed with doses above 60 and 100 pmol, respectively. Coronary angiography revealed that filling defects of dye were propagated from the third or distal branches to those of more proximal arteries when the doses of endothelin-1 were cumulatively infused into the LCX. Accordingly, lethal myocardial ischemia induced by endothelin-1 is produced by critical obstruction of rather small coronary vessels.
Tài liệu tham khảo
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415
Kodama M, Kanaide H, Abe S, Hirano K, Kai H, Nakamura M (1989) Endothelin-induced Ca-independent contraction of the porcine coronary artery. Biochem Biophys Res Commun 160: 1302–1308
Tippins JR, Antoniw JW, Maseri A (1989) Endothelin-1 is a potent constrictor in conductive and resistive coronary arteries. J Cardiovasc Pharmacol 13 (Suppl 5): S177-S179
Chester A, Clark J, Kauser S, Larkin S, Davies G, Yaccub M (1989) Endothelin is a potent constrictor of human coronary arteriesin vitro (abstract). J Am Coll Cardiol 13: 85A
Fukuda K, Hori S, Kusuhara M, Satoh T, Kyotani S, Handa S, Nakamura Y, Oono H, Yamaguchi K (1989) Effect of endothelin as a coronary vasoconstrictor in the Langendorff-perfused rat heart. Eur J Pharmacol 165: 301–304
Igarashi T, Aizawa Y, Tamura M, Ebe K, Yamaguchi T, Funazaki S, Shibata A (1989) Vasoconstrictor effect of endothelin on canine coronary artery (in Japanese). J Jpn Coll Angiol 29: 207–212
Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe T, Sakakibara S, Goto K, Masaki T (1988) Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85: 6964–6967
David E, Goldstein RE, Czaja JF, Feuerstein GZ (1989) Lethal ischemia due to intracoronary endothelin in pigs. Am J Physiol 257: H339-H343
Kurihara H, Yoshizumi M, Sugiyama T, Yamaoki K, Nagai R, Takaku F, Satoh H, Inui J, Yanagisawa M, Masaki T, Yazaki Y (1989) The possible role of endothelin-1 in the pathogenesis of coronary vasospasm. J Cardiovasc Pharmacol 13 (Suppl 5): S132-S137
Kurihara H, Yamaoki K, Nagai R, Yoshizumi M, Takaku F, Sato H, Inui L, Yazaki Y (1988) Coronary vasoconstriction produced by endothelin, a novel endothelium-derived vasoconstrictor peptide (abstract). Circulation 78 (Suppl II): II-171
Larkin S, Clarke J, Keogh B, Araujo L, Rhodes C, Brannan J, Taylor K, Davies G, Maseri A (1989) Intracoronary endothelin infusion induces transmural myocardial ischemia in the dog (abstract). J Am Coll Cardiol 13: 84A
Clozel JP, Clozel M (1989) Effects of endothelin on the coronary vascular bed in open-chest dogs. Circulation 65: 1193–1200
Gensini GG, Digiorgi S, Murad-Netto S, Black A (1962) Arteriographic demonstration of coronary artery spasm and its release after the use of a vasodilator in a case of angina pectoris and in the experimental animal. Angiology 13: 550–553
Shimokawa H, Tomoike H, Nabeyama S, Yamamoto H, Araki H, Tanaka K, Ishii Y, Nakamura M (1983) Coronary artery spasm induced in atherosclerotic miniature swine. Science 221: 560–561
Miyachi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisawa R, Goto K, Masaki T (1989) Increased plasma concentration of endothelin-1 and big endothelin in acute myocardial infarction. Lancet I: 53–54
Adachi H, Tomoike H, Nishijima H, Egashira S, Nakamura M (1989) Sustained dilation of large coronary artery by α-human atrial natriuretic peptide in conscious dogs: A comparison with nitroglycerin. Eur J Pharmacol 161: 189–196
Noguchi K, Tomoike H, Ootsubo H, Sakai K, Nakamura M (1981) Difference in site and time course of coronary dilating effects of tapidil, nitroglycerin and dipyridamole in anesthetized dogs. J Pharmacol Exp Ther 219: 809–814
Tomoike H, Ootsubo H, Sakai K, Kikuchi Y, Nakamura M (1981) Continuous measurements of the coronary artery diameterin situ. Am J Physiol 240: H73-H79
Vatner SF (1980) Correlation between acute reduction in myocardial blood flow and function in conscious dogs. Circ Res 47: 201–207
Hu JR, Von Harsdorf R, Lang RE (1988) Endothelin has potent inotropic effects in rat atria. Eur J Pharmacol 158: 275–278
Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T (1988) Positive inotropic action of novel vasoconstrictor peptide ET on guinea pig atria. Am J Physiol 255: H970-H973
Kitayosi T, Watanabe T, Shimamoto N (1989) Cardiovascular effects of endothelin in dogs: Positive inotropic actionin vivo. Eur J Pharmacol 166: 519–522
Watanabe T, Kusumoto K, Kitayoshi T, Shimamoto N (1989) Positive inotropic and vasoconstrictive effects of endothelin-1 inin vivo andin vitro experiments: Characteristics and the role of L-type calcium channels. J Cardiovasc Pharmacol 13 (Suppl 5): S108-S111
Underwood DC, Falotico R, Cheung W, Tobia AJ (1989) Dissociation of coronary vasoconstrictor and arrhythmogenic properties of endothelin in the dog. Circulation 80 (Suppl II): II-149
Gould KL, Lipscomb K, Hamilton GW (1974) Physiologic basis for assessing critical coronary stenosis. Am J Cardiol 33: 87–94
Tomoike H, Egashira K, Yamada A, Hayashi Y, Nakamura M (1987) Leukotriene C4- and D4-induced diffuse peripheral constriction of swine coronary artery accompanied by ST elevation on the electrocardiogram: Angiographic analysis. Circulation 76: 480–487